. Differences in the age at diagnosis in mutation carriers and non-carriers in particular breast cancer subtypes; (A) distribution according to the mutation status; (B) distribution according to the mutation status and ER status. * % = percentage of known; ** N = number of patients with ER-positive BC; *** patient could be counted in more than one event; pre -premenopausal; post -postmenopausal; TNBC -triple-negative BC; Antra -anthracyclines; Tax -taxanes; TAM -tamoxifen; AI -aromatase inhibitor; LHRH -luteinizing hormone-releasing hormone; Ref.
-reference.
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